Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

× No keyword cloud information.

31 in total

1. The role of [131I]Metaiodobenzylguanidine in the treatment of neural crest tumors. Proceedings of an international workshop. Rome, Italy, September 6-7, 1991.

Authors:
Journal: J Nucl Biol Med Date: 1991 Oct-Dec

Review 2. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma.

Authors: E L Bravo
Journal: Endocr Rev Date: 1994-06 Impact factor: 19.871

3. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.

Authors: F A Khafagi; B Shapiro; L M Fig; S Mallette; J C Sisson
Journal: J Nucl Med Date: 1989-04 Impact factor: 10.057

Review 4. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors: E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal: Eur J Nucl Med Date: 1993-08

5. Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.

Authors: M Nakajo; B Shapiro; J Glowniak; J C Sisson; W H Beierwaltes
Journal: J Nucl Med Date: 1983-12 Impact factor: 10.057

6. Salivary gland accumulation of meta-[131I]iodobenzylguanidine.

Authors: M Nakajo; B Shapiro; J C Sisson; D P Swanson; W H Beierwaltes
Journal: J Nucl Med Date: 1984-01 Impact factor: 10.057

7. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Authors: E P Krenning; W H Bakker; P P Kooij; W A Breeman; H Y Oei; M de Jong; J C Reubi; T J Visser; C Bruns; D J Kwekkeboom
Journal: J Nucl Med Date: 1992-05 Impact factor: 10.057

8. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma.

Authors: P D Mozley; C K Kim; J Mohsin; A Jatlow; E Gosfield; A Alavi
Journal: J Nucl Med Date: 1994-07 Impact factor: 10.057

Review 9. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors: C A Hoefnagel
Journal: Eur J Nucl Med Date: 1994-06

10. Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.

Authors: B L Shulkin; B Shapiro; M C Tobes; S W Shen; D M Wieland; L J Meyers; H T Lee; N A Petry; J C Sisson; W H Beierwaltes
Journal: J Nucl Med Date: 1986-07 Impact factor: 10.057